查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1836367

2032 年生命科学工具市场预测：按产品类型、技术、应用、最终用户和地区进行的全球分析

Life Science Tools Market Forecasts to 2032 - Global Analysis By Product Type (Instruments, Consumables, and Software & Services), Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球生命科学工具市场预计在 2025 年达到 1,882.9 亿美元，到 2032 年将达到 4,214.8 亿美元，预测期内的复合年增长率为 12.2%。

生命科学工具是专门用于支持生命系统（包括细胞、基因和蛋白质）研究的专用设备、化学品和技术。这些工具可帮助研究人员研究生物过程、开发治疗方法并进行诊断研究。这些工具包括实验室设备、耗材、软体解决方案和分析平台，可提高生物技术、药物开发和更广泛的生命科学研究中实验的精确度、速度和可靠性。

生物製药研发的成长

标靶治疗和生技药品的需求日益增长，促使企业投资高通量筛检和先进的分析平台。基因组学、蛋白质组学和细胞检测领域的创新，使人们能够更深入地了解疾病机制。 CRISPR 基因编辑和单细胞定序等新技术正在彻底改变药物研发流程。学术机构与生物技术公司之间的合作正在加速转化研究和临床试验的准备。随着个人化医疗的发展，对精密生命科学工具的需求持续飙升。

先进设备高成本

尖端生命科学设备的高昂成本仍是市场成长的一大障碍。质谱、流式细胞技术和次世代定序等先进技术需要大量的资本投入和熟练的人员。小型实验室和新兴企业通常难以购买此类设备，这限制了它们获得先进研究能力的机会。维护、校准和软体升级进一步增加了营运负担。法规遵循和资料完整性要求也增加了复杂性和拥有成本。这些财务负担可能会减缓采用率，尤其是在资源受限的环境中。

临床诊断应用日益广泛

生命科学工具日益融入临床诊断领域，代表着巨大的成长机会。分子诊断、液态切片和生物标记分析正成为疾病检测和监测的核心。医院和诊断实验室越来越多地采用PCR系统、微阵列和免疫测量平台，以提高准确性和速度。就地检验和分散式诊断的兴起推动了对紧凑型自动化设备的需求。人工智慧分析和云端基础的数据共用正在改变诊断工作流程，并实现即时决策。随着精准医疗的扩展，生命科学工具在提供个人化医疗方面发挥关键作用。

供应链脆弱性与地缘政治风险

依赖有限供应商提供的专用组件和试剂，使得该行业容易受到干扰。贸易限制、出口管制和地区衝突可能会延误製造和分销时间表。半导体和医疗材料的短缺持续影响生产的扩充性。企业越来越多地采用数位供应链平台和预测分析来降低这些风险。然而，如果没有多元化的采购和紧急时应对计画，市场相关人员将面临潜在的瓶颈和交付延迟。

COVID-19的影响：

新冠疫情颠覆了生命科学工具的格局，既带来了挑战，也带来了创新。封锁和旅行限制扰乱了供应链，延误了设备在科学研究和临床环境中的部署。然而，这场危机加速了远距离诊断、数位实验室管理和云端基础协作工具的采用。紧急使用授权和加速核准使得诊断平台和试剂的快速部署成为可能。 PCR 仪器、定序工具和病毒检测套件的需求激增，推动了短期市场成长。展望未来，后疫情时代策略如今强调的是具有韧性、自动化和去中心化的研究基础设施。

预计设备部门将成为预测期内最大的部门

预计仪器仪表领域将在预测期内占据最大的市场份额。这一领先地位可归因于分析、影像和定序仪器在研究和临床应用中的广泛应用。多路復用、小型化和自动化技术的进步正在提高仪器的性能和吞吐量。基因组学、蛋白质组学和细胞生物学对精密工具的旺盛需求正在推动该领域的扩张。人工智慧和物联网与仪器仪表平台的整合正在实现智慧诊断和预测分析。随着实验室的现代化，仪器仍然是生命科学创新的支柱。

预计生物技术公司部门在预测期内将见证最高的复合年增长率。

预计生物技术公司将在预测期内实现最高成长率。对开发新型疗法和诊断方法的关注推动了对尖端研究工具的需求。新兴企业和中型企业正在利用云端基础的平台和人工智慧主导的分析来加快发现进度。与学术机构和合约研究组织 (CRO) 的策略合作伙伴关係正在扩大先进设备的使用范围。创业投资资金和政府津贴的流入正在支持技术创新和基础设施建设。随着生技公司业务规模的扩大，它们对生命科学工具的依赖也日益增加。

最大份额区域：

由于医疗基础设施的快速扩张和生物医学研究投资的不断增加，预计亚太地区将在预测期内占据最大的市场份额。中国、印度和日本等国家正在优先考虑本地生产和技术应用。政府正倡议培育创新中心并奖励研发合作。该地区正在大规模采用人工智慧辅助诊断、机器人实验室自动化和数位病理学。全球和区域公司之间的策略联盟正在增强市场渗透和技术转移。

复合年增长率最高的地区：

在预测期内，北美预计将呈现最高的复合年增长率，这得益于其技术领先地位和雄厚的研发资金。美国和加拿大在基因定序、实验室自动化和人工智慧诊断技术创新方面处于领先地位。监管机构正在简化下一代工具的核准途径，加速其商业化进程。医院和研究中心正在整合物联网和数据分析，以优化实验室工作流程和资源利用率。优惠的报销政策和强大的创业投资生态系统正在支持这些技术的快速应用。随着精准医疗和数位健康的发展，北美将继续引领全球生命科学的进步。

免费客製化服务：

此报告的订阅者可以使用以下免费自订选项之一：

  • 公司简介
    • 对最多三家其他市场公司进行全面分析
    • 主要企业的SWOT分析（最多3家公司）
  • 区域细分
    • 根据客户兴趣对主要国家进行的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究材料
    • 主要研究资料
    • 次级研究资讯来源
    • 先决条件

第三章市场走势分析

  • 驱动程式
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 技术分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

第五章全球生命科学工具市场（依产品类型）

  • 装置
    • 分析设备
    • 显微镜工具
    • 实验设备
  • 耗材
    • 试剂和套件
    • 实验室器皿和塑胶器皿
  • 软体和服务
    • 数据分析软体
    • 维护和校准服务
    • 实验室资讯管理系统（LIMS）

6. 全球生命科学工具市场（按技术）

  • PCR和qPCR
  • 层析法
  • 光谱学
  • 定序技术
  • 细胞分析和成像

7. 全球生命科学工具市场（按应用）

  • 药物研发
  • 分子生物学
  • 学术研究机构
  • 基因组学和蛋白​​质组学
  • 生物技术调查
  • 临床诊断
  • 其他用途

第 8 章：全球生命科学工具市场（按最终用户划分）

  • 製药和生物製药公司
  • 生技公司
  • 合约研究组织（CRO）
  • 医院和诊断实验室
  • 学术和政府研究组织
  • 其他最终用户

9. 全球生命科学工具市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十章：重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十一章 公司概况

  • Berkshire Hathaway
  • Deutsche Bank
  • JPMorgan Chase
  • S&P Global
  • Visa
  • Citigroup
  • Mastercard
  • BlackRock
  • Bank of America
  • HSBC
  • Industrial and Commercial Bank of China（ICBC）
  • Goldman Sachs
  • China Construction Bank
  • Morgan Stanley
  • Wells Fargo
Product Code: SMRC31491

According to Stratistics MRC, the Global Life Science Tools Market is accounted for $188.29 billion in 2025 and is expected to reach $421.48 billion by 2032 growing at a CAGR of 12.2% during the forecast period. Life Science Tools are specialized instruments, chemicals, and technologies designed to support research on living systems, including cells, genes, and proteins. They assist researchers in investigating biological processes, developing therapies, and conducting diagnostic studies. These tools include lab devices, consumables, software solutions, and analytical platforms that improve the precision, speed, and reliability of experiments in biotechnology, pharmaceutical development, and broader life science research.

Market Dynamics:

Driver:

Growth in biopharmaceutical R&D

Increasing demand for targeted therapies and biologics is pushing companies to invest in high-throughput screening and advanced analytical platforms. Innovations in genomics, proteomics, and cell-based assays are enabling deeper insights into disease mechanisms. Emerging technologies such as CRISPR gene editing and single-cell sequencing are revolutionizing drug discovery pipelines. Collaborations between academic institutions and biotech firms are accelerating translational research and clinical trial readiness. As personalized medicine gains momentum, the need for sophisticated life science tools continues to surge.

Restraint:

High cost of advanced instruments

The steep cost of cutting-edge life science instruments remains a significant barrier to market growth. Sophisticated technologies like mass spectrometry, flow cytometry, and next-generation sequencing require substantial capital investment and skilled personnel. Smaller laboratories and startups often struggle to afford these tools, limiting their access to advanced research capabilities. Maintenance, calibration, and software upgrades further add to the operational burden. Regulatory compliance and data integrity requirements also increase the complexity and cost of ownership. This financial strain can slow adoption rates, particularly in resource-constrained settings.

Opportunity:

Increased adoption in clinical diagnostics

The growing integration of life science tools into clinical diagnostics presents a major growth opportunity. Molecular diagnostics, liquid biopsy, and biomarker analysis are becoming central to disease detection and monitoring. Hospitals and diagnostic labs are increasingly deploying PCR systems, microarrays, and immunoassay platforms to enhance accuracy and speed. The rise of point-of-care testing and decentralized diagnostics is driving demand for compact, automated instruments. AI-powered analytics and cloud-based data sharing are transforming diagnostic workflows and enabling real-time decision-making. As precision medicine expands, life science tools are playing a pivotal role in personalized healthcare delivery.

Threat:

Supply chain fragilities and geopolitical risks

Dependence on specialized components and reagents from limited suppliers makes the industry susceptible to disruptions. Trade restrictions, export controls, and regional conflicts can delay manufacturing and distribution timelines. Shortages of semiconductors and medical-grade materials continue to impact production scalability. Companies are increasingly adopting digital supply chain platforms and predictive analytics to mitigate these risks. However, without diversified sourcing and contingency planning, market players face potential bottlenecks and delivery delays.

Covid-19 Impact:

The COVID-19 pandemic reshaped the life science tools landscape, triggering both challenges and innovations. Lockdowns and travel restrictions disrupted supply chains and delayed instrument installations across research and clinical settings. However, the crisis accelerated the adoption of remote diagnostics, digital lab management, and cloud-based collaboration tools. Emergency use authorizations and fast-track approvals enabled rapid deployment of diagnostic platforms and reagents. Demand surged for PCR machines, sequencing tools, and viral detection kits, driving short-term market growth. Post-pandemic strategies now emphasize resilience, automation, and decentralized research infrastructure to future-proof operations.

The instruments segment is expected to be the largest during the forecast period

The instruments segment is expected to account for the largest market share during the forecast period. This leadership stems from the widespread use of analytical, imaging, and sequencing devices across research and clinical applications. Technological advancements in multiplexing, miniaturization, and automation are enhancing instrument performance and throughput. High demand for precision tools in genomics, proteomics, and cell biology is fueling segment expansion. Integration of AI and IoT into instrument platforms is enabling smart diagnostics and predictive analytics. As laboratories modernize, instruments remain the backbone of life science innovation.

The biotechnology companies segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the biotechnology companies segment is predicted to witness the highest growth rate. Their focus on developing novel therapeutics and diagnostics is driving demand for cutting-edge research tools. Startups and mid-sized firms are leveraging cloud-based platforms and AI-driven analytics to accelerate discovery timelines. Strategic partnerships with academic institutions and CROs are expanding access to advanced instrumentation. Venture capital inflows and government grants are supporting innovation and infrastructure development. As biotech firms scale operations, their reliance on life science tools continues to intensify.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, due to rapid expansion of healthcare infrastructure and rising investments in biomedical research. Countries like China, India, and Japan are prioritizing local manufacturing and technology adoption. Government initiatives are fostering innovation hubs and incentivizing R&D collaborations. The region is embracing AI-assisted diagnostics, robotic lab automation, and digital pathology at scale. Strategic alliances between global players and regional firms are enhancing market penetration and technology transfer.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, driven by technological leadership and robust R&D funding. The U.S. and Canada are at the forefront of innovations in genomic sequencing, lab automation, and AI-powered diagnostics. Regulatory bodies are streamlining approval pathways for next-gen tools, accelerating commercialization. Hospitals and research centers are integrating IoT and data analytics to optimize lab workflows and resource utilization. Favorable reimbursement policies and strong venture capital ecosystems are supporting rapid adoption. As precision medicine and digital health evolve, North America continues to lead global life science advancements.

Key players in the market

Some of the key players in Life Science Tools Market include Berkshire Hathaway, Deutsche Bank, JPMorgan Chase, S&P Global, Visa, Citigroup, Mastercard, BlackRock, Bank of America, HSBC, Industrial and Commercial Bank of China (ICBC), Goldman Sachs, China Construction Bank, Morgan Stanley, and Wells Fargo.

Key Developments:

In September 2025, S&P Global announced a strategic collaboration with investment firms Cambridge Associates and Mercer to deliver comprehensive private markets performance analytics, set to launch in beta by year-end 2025. The collaboration will transform how General Partners (GPs) and Limited Partners (LPs) in private markets contribute critical market intelligence.

In September 2025, Citi and Dandelion, announced a collaboration to enhance cross-border payments, powered by the integration of Citi's cross-border payments solution WorldLink(R) Payment Services and Dandelion's expansive digital wallet network. The collaboration empowers Citi's institutional clients to deliver near-instant, full-value payments into digital wallets across the globe, with near 24/7 availability.

Product Types Covered:

  • Instruments
  • Consumables
  • Software and Services

Technologies Covered:

  • PCR & qPCR
  • Chromatography
  • Spectroscopy
  • Sequencing Technologies
  • Cell Analysis & Imaging

Applications Covered:

  • Drug Discovery & Development
  • Molecular Biology
  • Academic & Research Institutes
  • Genomics & Proteomics
  • Biotechnology Research
  • Clinical Diagnostics
  • Other Applications

End Users Covered:

  • Pharmaceutical & Biopharmaceutical Companies
  • Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Hospitals & Diagnostic Laboratories
  • Academic & Government Research Institutes
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Life Science Tools Market, By Product Type

  • 5.1 Introduction
  • 5.2 Instruments
    • 5.2.1 Analytical Instruments
    • 5.2.2 Microscopy Tools
    • 5.2.3 Laboratory Equipment
  • 5.3 Consumables
    • 5.3.1 Reagents & Kits
    • 5.3.2 Labware & Plasticware
  • 5.4 Software & Services
    • 5.4.1 Data Analysis Software
    • 5.4.2 Maintenance & Calibration Services
    • 5.4.3 Laboratory Information Management Systems (LIMS)

6 Global Life Science Tools Market, By Technology

  • 6.1 Introduction
  • 6.2 PCR & qPCR
  • 6.3 Chromatography
  • 6.4 Spectroscopy
  • 6.5 Sequencing Technologies
  • 6.6 Cell Analysis & Imaging

7 Global Life Science Tools Market, By Application

  • 7.1 Introduction
  • 7.2 Drug Discovery & Development
  • 7.3 Molecular Biology
  • 7.4 Academic & Research Institutes
  • 7.5 Genomics & Proteomics
  • 7.6 Biotechnology Research
  • 7.7 Clinical Diagnostics
  • 7.8 Other Applications

8 Global Life Science Tools Market, By End User

  • 8.1 Introduction
  • 8.2 Pharmaceutical & Biopharmaceutical Companies
  • 8.3 Biotechnology Companies
  • 8.4 Contract Research Organizations (CROs)
  • 8.5 Hospitals & Diagnostic Laboratories
  • 8.6 Academic & Government Research Institutes
  • 8.7 Other End Users

9 Global Life Science Tools Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Berkshire Hathaway
  • 11.2 Deutsche Bank
  • 11.3 JPMorgan Chase
  • 11.4 S&P Global
  • 11.5 Visa
  • 11.6 Citigroup
  • 11.7 Mastercard
  • 11.8 BlackRock
  • 11.9 Bank of America
  • 11.10 HSBC
  • 11.11 Industrial and Commercial Bank of China (ICBC)
  • 11.12 Goldman Sachs
  • 11.13 China Construction Bank
  • 11.14 Morgan Stanley
  • 11.15 Wells Fargo

List of Tables

  • Table 1 Global Life Science Tools Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Life Science Tools Market Outlook, By Product Type (2024-2032) ($MN)
  • Table 3 Global Life Science Tools Market Outlook, By Instruments (2024-2032) ($MN)
  • Table 4 Global Life Science Tools Market Outlook, By Analytical Instruments (2024-2032) ($MN)
  • Table 5 Global Life Science Tools Market Outlook, By Microscopy Tools (2024-2032) ($MN)
  • Table 6 Global Life Science Tools Market Outlook, By Laboratory Equipment (2024-2032) ($MN)
  • Table 7 Global Life Science Tools Market Outlook, By Consumables (2024-2032) ($MN)
  • Table 8 Global Life Science Tools Market Outlook, By Reagents & Kits (2024-2032) ($MN)
  • Table 9 Global Life Science Tools Market Outlook, By Labware & Plasticware (2024-2032) ($MN)
  • Table 10 Global Life Science Tools Market Outlook, By Software & Services (2024-2032) ($MN)
  • Table 11 Global Life Science Tools Market Outlook, By Data Analysis Software (2024-2032) ($MN)
  • Table 12 Global Life Science Tools Market Outlook, By Maintenance & Calibration Services (2024-2032) ($MN)
  • Table 13 Global Life Science Tools Market Outlook, By Laboratory Information Management Systems (LIMS) (2024-2032) ($MN)
  • Table 14 Global Life Science Tools Market Outlook, By Technology (2024-2032) ($MN)
  • Table 15 Global Life Science Tools Market Outlook, By PCR & qPCR (2024-2032) ($MN)
  • Table 16 Global Life Science Tools Market Outlook, By Chromatography (2024-2032) ($MN)
  • Table 17 Global Life Science Tools Market Outlook, By Spectroscopy (2024-2032) ($MN)
  • Table 18 Global Life Science Tools Market Outlook, By Sequencing Technologies (2024-2032) ($MN)
  • Table 19 Global Life Science Tools Market Outlook, By Cell Analysis & Imaging (2024-2032) ($MN)
  • Table 20 Global Life Science Tools Market Outlook, By Application (2024-2032) ($MN)
  • Table 21 Global Life Science Tools Market Outlook, By Drug Discovery & Development (2024-2032) ($MN)
  • Table 22 Global Life Science Tools Market Outlook, By Molecular Biology (2024-2032) ($MN)
  • Table 23 Global Life Science Tools Market Outlook, By Academic & Research Institutes (2024-2032) ($MN)
  • Table 24 Global Life Science Tools Market Outlook, By Genomics & Proteomics (2024-2032) ($MN)
  • Table 25 Global Life Science Tools Market Outlook, By Biotechnology Research (2024-2032) ($MN)
  • Table 26 Global Life Science Tools Market Outlook, By Clinical Diagnostics (2024-2032) ($MN)
  • Table 27 Global Life Science Tools Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 28 Global Life Science Tools Market Outlook, By End User (2024-2032) ($MN)
  • Table 29 Global Life Science Tools Market Outlook, By Pharmaceutical & Biopharmaceutical Companies (2024-2032) ($MN)
  • Table 30 Global Life Science Tools Market Outlook, By Biotechnology Companies (2024-2032) ($MN)
  • Table 31 Global Life Science Tools Market Outlook, By Contract Research Organizations (CROs) (2024-2032) ($MN)
  • Table 32 Global Life Science Tools Market Outlook, By Hospitals & Diagnostic Laboratories (2024-2032) ($MN)
  • Table 33 Global Life Science Tools Market Outlook, By Academic & Government Research Institutes (2024-2032) ($MN)
  • Table 34 Global Life Science Tools Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.